Ginsenoside Rg3 upregulates myotube formation and mitochondrial function, thereby protecting myotube atrophy induced by tumor necrosis factor-alpha
- Authors
- Lee, Sang-Jin; Bae, Ju Hyun; Lee, Hani; Lee, Hyunji; Park, Jongsun; Kang, Jong-Sun; Bae, Gyu-Un
- Issue Date
- Oct-2019
- Publisher
- ELSEVIER IRELAND LTD
- Keywords
- Akt/mTOR pathway; Ginsenoside Rg3; Mitochondria; Muscle atrophy; PGC1 alpha
- Citation
- JOURNAL OF ETHNOPHARMACOLOGY, v.242
- Journal Title
- JOURNAL OF ETHNOPHARMACOLOGY
- Volume
- 242
- URI
- https://scholarworks.sookmyung.ac.kr/handle/2020.sw.sookmyung/2792
- DOI
- 10.1016/j.jep.2019.112054
- ISSN
- 0378-8741
1872-7573
- Abstract
- Edumpharmacological relevance: Ginsenoside Rg3 from Panax ginseng has reported to have multiple pharmacological activities including anti-diabetics, anti-inflammation and anti-cancer. However, the effect of ginsenoside Rg3 on myogenic differentiation and muscle atrophy is unknown. Aim to the study: In this study, we investigated the myogenic effect and underlying molecular mechanisms of ginsenoside Rg3 on myotube atrophy induced by tumor necrosis factor-alpha (TNF-alpha). Materials and methods: C2C12 myoblasts were induced to differentiate for one day followed by the treatment of TNF-alpha along with vehicle or ginsenoside Rg3 for additional 2 days and subjected to immunoblotting, immunocytochemistry, quantitative RT-PCR and biochemical analysis for mitochondrial function. Results: Ginsenoside Rg3 promotes myogenic differentiation and multinucleated myotube formation through Akt activation in a dose-dependent manner, without any cytotoxicity. Ginsenoside Rg3 treatment restores myotube formation and increases myotube diameters under TNF-alpha-treated conditions. Ginsenoside Rg3 enhances Akt/mTOR (mammalian target of rapamycin) signaling that in turn stimulates muscle-specific gene expression such as myosin heavy chain (MHC) and Myogenin, and suppresses the expression of muscle-specific ubiquitin ligases. In addition, ginsenoside Rg3 in TNF-alpha-treated myotubes significantly inhibits the production of mitochondrial ROS and restores mitochondrial membrane potential (MMP) and ATP contents. Furthermore, ginsenoside Rg3 upregulates the activities and expression of peroxisome proliferator-activated receptor-gamma coactivator-1 alpha (PGC1 alpha) and the mitochondrial biogenetic transcription factors, nuclear respiratory factor-1 (NRF1) and mitochondrial transcription factor A (Tfam) in TNF-alpha-induced myotube atrophy. Conclusions: This study provides a mechanistic insight into the effect of ginsenoside Rg3 on myogenic differentiation and myotube atrophy, suggesting that ginsenoside Rg3 has a promising potential as a therapeutic or neutraceutical remedy to intervene muscle weakness and atrophy.
- Files in This Item
-
Go to Link
- Appears in
Collections - 약학대학 > 약학부 > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.sookmyung.ac.kr/handle/2020.sw.sookmyung/2792)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.